FRA1 is recruited to the Cyclin A2 gene promoter and increases JUNB expression, which in turn binds to the Cyclin A2 gene promoter and promotes its expression, which has been reported in breast and thyroid cancers [130]. This evidence concerns the gene CCNA2 and thyroid cancer.